Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2025-01-15
2025-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EFT intervention
The implementation will be carried out in accordance with EFT implementation protocols. In this context, it will be completed with 4 interviews, once a week for pregnant women. i Each EFT session will last 15 minutes.
EFT intervention
The intervention groups will be followed up for 4 weeks and 4 EFT therapies will be applied, one session per week.
Control grup
There will be no intervention. Women in the intervention groups will be followed up for 4 weeks and will receive standardised care. The final test will be administered in the postnatal period
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EFT intervention
The intervention groups will be followed up for 4 weeks and 4 EFT therapies will be applied, one session per week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak, understand and write Turkish,
* 18 years of age or older,
* Residing in Konya province,
* No disability for vaginal delivery,
* Primigravida,
* Anxiety level of 1 or higher when measured with the subjective discomfort unit scale,
* Pregnant women who are at 32 weeks of gestation or above according to the last menstrual date or according to calculations made with USG data for pregnant women who do not know the last menstrual date.
Exclusion Criteria
* Those who have undergone infertility treatment,
* Those with any fetal health problems,
* Those with physical or mental illnesses,
* Those with a cesarean section indication or who plan to deliver via cesarean section,
* Those with chronic and/or psychiatric health issues and those who have participated in any childbirth preparation education were excluded from the study.
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EMEL EGE
UNKNOWN
KTO Karatay University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merve Yazar
Lecturer, PhD (c)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KTO Karatay University
Konya, Konya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MerveU
Identifier Type: -
Identifier Source: org_study_id